KIM
RVPH

Karpus Investment Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Karpus Investment Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-658
Closed -$138K – 229
2020
Q1 		$138K Sell
658
-18,165
-97% -$3.81M 0.01% 217
2019
Q4 		$3.94M Sell
18,823
-12
-0.1% -$2.5K 0.13% 106
2019
Q3 		$3.9M Buy
18,835
+1,092
+6% +$225K 0.15% 108
2019
Q2 		$3.63M Buy
17,743
+42
+0.2% +$8.55K 0.13% 109
2019
Q1 		$3.58M Buy
+17,701
New +$3.55M 0.13% 113

Other funds holding RVPH

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Karpus Investment Management's RVPH Position: Q2 2020 in Review

Karpus Investment Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2020, closing a stake of 658 shares — an estimated $138K sold.

Karpus Investment Management first reported a position in RVPH in Q1 2019 and held it in 5 quarters. The position peaked at $3.94M in Q4 2019. 16 funds tracked by Wall St. Rank hold RVPH as of Q2 2020.

  • Karpus Investment Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2020 after selling out during the quarter.
  • Karpus Investment Management sold 658 REVIVA PHARMA HLDGS INC shares in Q2 2020, an estimated $138K.
  • Karpus Investment Management first reported a position in REVIVA PHARMA HLDGS INC in Q1 2019 and held it in 5 quarters.
  • Karpus Investment Management's REVIVA PHARMA HLDGS INC position peaked at $3.94M in Q4 2019.
  • 16 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2020.

Based on Karpus Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.